Crestor Advisory Committee For Primary Prevention Of CV Disease To Focus On Adverse Events
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca's JUPITER study could be added to the statin's label if advisory committee is not troubled by signals of gastrointestinal disorders, "confusional state" and diabetes.